1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gemcitabine|DRUG: Sorafenib|DRUG: Placebo|DRUG: Capecitabine
Sponsor: Accelerated Community Oncology Research Network
Collaborators: Amgen